Vol 5 (September 30, 2022): Precision Cancer Medicine

Editorial Commentary
Uncommon EGFR mutations in non-small-cell lung cancer
Marco Russano, Giuseppe Perrone, Giuseppina Rita Di Fazio, Alessandro Galletti, Fabrizio Citarella, Valentina Santo, Leonardo Brunetti, Alessia Vendittelli, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
30  
Case Report
Giant perivascular spaces in brain: case report with a comprehensive literature review
Gaurav Cheraya, Suryansh Bajaj, Salil Sharma, Darshan Gandhi, Jignesh Shah, Nisarg Parikh, Nishant Gupta
Precision Cancer Medicine  
2022;
5:
29  
Review Article
Moving through rare lung cancer histologies: a narrative review on diagnosis and treatment of selected infrequent entities
Chiara Pisano, Gianluca Witel, Marco De Filippis, Angela Listì, Francesca Napoli, Luisella Righi, Silvia Novello, Paolo Bironzo
Precision Cancer Medicine  
2022;
5:
27  
Review Article
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
Maria Vittoria Di Marco, Claudia Voena
Precision Cancer Medicine  
2022;
5:
26  
Review Article
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
Francesca Parisi, Giovanni Rossi, Federica Biello, Marco Tagliamento, Giulia Barletta, Lodovica Zullo, Eugenia Cella, Gianluca Sacco, Chiara Dellepiane, Elisa Bennicelli, Diletta Favero, Angela Alama, Simona Coco, Silvia Marconi, Linda Zinoli, Enrica Teresa Tanda, Paolo Pronzato, Erika Rijavec, Carlo Genova
Precision Cancer Medicine  
2022;
5:
25  
Review Article
Clinical implications of liquid biopsies in urogenital tumors: a narrative review
Laudy Chehade, Ali H. Abdel Sater, Hampig Raphael Kourie, Deborah Mukherji, Ali Shamseddine
Precision Cancer Medicine  
2022;
5:
24  
Review Article
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Sandra Baldacci, Sara Maio, Claudia Meschi, Davide Chimera, Sofia Tagliaferro, Anna Antonietta Angino, Patrizia Silvi, Francesco Pistelli, Laura Carrozzi
Precision Cancer Medicine  
2022;
5:
23  
Editorial
Lung cancer in women
Editta Baldini
Precision Cancer Medicine  
2022;
5:
22  
Editorial
How should clinicians manage metastatic non-small cell lung cancer patients with BRAF non-V600E mutations?
Edyta Maria Urbanska
Precision Cancer Medicine  
2022;
5:
21